Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Chemours Company - CC
ClaimsFiler is reminding investors who suffered losses exceeding $100,000 in The Chemours Company (NYSE: CC) to file lead plaintiff applications by December 7, 2026, in a securities class action lawsuit. The lawsuit alleges that Chemours and its executives failed to disclose material information, leading to an 18.63% drop in share price after the company cut its full-year adjusted EBITDA guidance and admitted to an oversupplied channel.
The Chemours Company Announces Retirement of Kristine Wellman and Appointment of Amy Rocklin as General Counsel
The Chemours Company announced the retirement of Kristine Wellman, Senior Vice President, General Counsel & Corporate Secretary, effective May 2027. Concurrently, Amy Rocklin will join Chemours as Senior Vice President, General Counsel & Corporate Secretary, starting January 4, 2027. Wellman will transition to SVP, Senior Counsel to the President and CEO during this period.
Chemours names Amy Rocklin as general counsel, Wellman to retire By Investing.com
The Chemours Company announced that Amy Rocklin will replace Kristine Wellman as Senior Vice President, General Counsel & Corporate Secretary, effective January 4, 2027. Wellman, who joined Chemours in 2014, will transition to SVP, Senior Counsel to the President and CEO until May 2027. Rocklin brings over two decades of legal, business, and scientific experience to the role.
Chemours names Amy Rocklin as general counsel as Kristine Wellman retires
The Chemours Company announced that Kristine Wellman, Senior Vice President, General Counsel, and Corporate Secretary, will retire. Amy Rocklin will succeed Wellman in the same role, effective January 4, 2027. Wellman will transition to SVP, Senior Counsel to the President and CEO until May 2027.
Chemours' Actions Toward Circularity
Chemours is committed to building a more circular economy by improving manufacturing processes, closing the loop on water and waste, and promoting product and packaging reuse and recycling. The company plans to announce specific targets and key performance indicators in future sustainability reporting to ensure a positive circularity trajectory. Initiatives include assessing local water contexts, redesigning packaging to reduce waste and emissions, and implementing a pallet refurbishment program.
The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC (KSF) is reminding investors in The Chemours Company (NYSE: CC) that they have until December 7, 2026, to file lead plaintiff applications in a securities class action lawsuit. The lawsuit alleges that Chemours and its executives failed to disclose material information, leading to an 18% stock decline after the company cut its full-year adjusted EBITDA guidance and admitted to an oversupplied refrigerant aftermarket channel. Investors who purchased Chemours securities between February 20, 2026, and August 4, 2026, are affected.
The Chemours Company (NYSE: CC) SHAREHOLDER ALERT:
The Portnoy Law Firm has filed a securities class action lawsuit against The Chemours Company (NYSE: CC) on behalf of investors who purchased stock between February 20, 2026, and August 4, 2026. The lawsuit alleges that Chemours made misleading statements regarding demand for its Opteon refrigeration products, leading to a significant stock price drop after the company announced reduced full-year adjusted EBITDA guidance. Investors with losses have until December 7, 2026, to seek appointment as lead plaintiff.
DEQ tells Chemours to fix deficiencies in PFAS cleanup plans
The N.C. Department of Environmental Quality (DEQ) has directed Chemours to address significant deficiencies in its plans for cleaning up PFAS contamination in groundwater across southeastern North Carolina. The DEQ highlighted problems in Chemours' assessment and corrective action plan, emphasizing the need for a full assessment of contaminated soil and groundwater, revised cleanup strategies, and an expanded scope to include all PFAS associated with the facility. This directive is a step in a recent $590 million settlement aimed at expediting Chemours' long-term cleanup efforts.
Investor Notice: Chemours (NYSE:CC) Sued for Securities Fraud after Opteon Demand Issues Cause 18% Stock Drop – Contact BFA Law before Class Action Deadline
The Chemours Company (NYSE:CC) and its senior executives are facing a securities fraud class action lawsuit following an 18.63% stock drop on August 5, 2026. The lawsuit alleges that Chemours misrepresented the demand for its Opteon refrigeration products, failing to disclose that customers were oversupplied due to the U.S. AIM Act transition. Investors have until December 7, 2026, to seek appointment as lead plaintiff and are encouraged to contact Bleichmar Fonti & Auld LLP for more information.
CC Deadline Alert: Levi & Korsinsky Reminds The Chemours Company (CC) Investors of Securities Class Action Deadline on December 7, 2026
Levi & Korsinsky, LLP is alerting investors of The Chemours Company (NYSE: CC) about a pending securities class action lawsuit, with a lead plaintiff deadline of December 7, 2026. The lawsuit alleges that Chemours management overstated aftermarket demand for Opteon refrigerants, leading to a significant stock drop on August 5, 2026, after the company cut its 2026 adjusted EBITDA outlook. Investors who purchased CC shares between February 20, 2026, and August 4, 2026, and incurred losses may be eligible to seek compensation.
Chemours faces nearly 40 new cleanup requirements 7 years after 'forever chemicals' deal
Seven years after agreeing to clean up PFAS pollution in the Cape Fear River, Chemours faces nearly 40 new cleanup requirements from North Carolina's Department of Environmental Quality. The contamination has impacted over 500,000 residents, preventing them from safely drinking the water or eating fish. Advocacy groups and community members continue to push for Chemours to be held fully accountable, emphasizing that the recent state action is a step in the right direction but more work is needed.
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Chemours Company (NYSE: CC) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Bronstein Gewirtz & Grossman, LLC has announced a class action lawsuit against The Chemours Company (NYSE: CC) for alleged violations of federal securities laws. The lawsuit is open to investors who purchased Chemours securities between February 20, 2026, and August 4, 2026, and seeks to recover damages for purported misrepresentations regarding demand for Opteon products and unreliable financial guidance. The deadline for investors to request to be appointed lead plaintiff is December 7, 2026.
CC Deadline Imminent: BFA Law Reminds Chemours Investors of the Upcoming December 7 Deadline in Securities Fraud Class Action to Recover Losses
Bleichmar Fonti & Auld LLP has announced a securities fraud class action lawsuit against The Chemours Company (NYSE:CC) and its executives following a significant stock drop. Investors have until December 7, 2026, to apply for lead plaintiff status. The lawsuit alleges that Chemours misrepresented demand for its Opteon products, leading to an oversupplied channel and an 18.63% stock drop on August 5, 2026.
NC orders Chemours to step up PFAS cleanup despite $600M settlement
North Carolina regulators have ordered Chemours to intensify its "forever chemical" cleanup efforts, citing "significant deficiencies" in the company's work despite a recent nearly $600 million settlement. The state's Department of Environmental Quality emphasized that it expects Chemours to clean up all polluted areas, holding the company accountable for widespread PFAS contamination. Environmentalists and state officials alike are pushing for more rigorous remediation, especially with a renewed focus on environmental concerns under the new legislative landscape.
Robbins LLP Urges CC Shareholders to Contact the Firm for Information About Leading The Chemours Company Class Action Lawsuit
Robbins LLP is urging shareholders of The Chemours Company (NYSE: CC) to contact the firm regarding a class action lawsuit. The lawsuit alleges that Chemours materially overstated demand for its Opteon products, leading to unreliable financial guidance for fiscal year 2026. This misrepresentation allegedly caused Chemours' stock price to drop significantly after the company announced reduced full-year guidance and admitted to overselling products.
CC INVESTOR ALERT: Bragar Eagel & Squire, P.C. Urges The Chemours Company Investors to Contact the Firm Before December 7th Seeking Lead Plaintiff Role
Bragar Eagel & Squire, P.C. has filed a class action lawsuit against The Chemours Company (NYSE: CC) on behalf of investors who purchased securities between February 20, 2026, and August 4, 2026. The lawsuit alleges that Chemours made materially false and misleading statements regarding the demand for its Opteon products, which were allegedly overstated, leading to unreliable financial guidance for 2026. Investors who suffered losses and wish to apply for the lead plaintiff role must contact the firm by December 7, 2026.
NCDEP Vows to Hold Chemours Accountable for PFAS Contamination
North Carolina environmental regulators have strongly criticized Chemours' proposal for cleaning up PFAS contamination, stating it violates a consent order. The state's Department of Environmental Quality (DEQ) found multiple inadequacies in Chemours' plan, citing missing data, substandard sampling, and flawed analyses that underestimate the extent of pollution and health risks across at least 10 counties. DEQ Secretary Reid Wilson affirmed the department's commitment to holding Chemours accountable, regardless of how long the cleanup takes, while Chemours stated it would review the feedback and respond through established processes.
CC UPCOMING DEADLINE: SueWallSt Alerts The Chemours Company Stockholders of Securities Class Action - Contact the Firm
SueWallSt is notifying stockholders of The Chemours Company (NYSE: CC) about a pending securities class action lawsuit. The lawsuit alleges that Chemours made materially false and misleading statements regarding its growth outlook tied to the U.S. AIM Act, specifically concerning an overstocked refrigerant aftermarket channel that impacted its 2026 guidance. Investors who purchased Chemours securities between February 20, 2026, and August 4, 2026, and suffered losses, have until December 7, 2026, to seek appointment as lead plaintiff.
State demands Chemours conduct broader PFAS cleanup, testing in Cape Fear
The North Carolina Department of Environmental Quality (NCDEQ) has issued a formal notice to Chemours, demanding a broader cleanup and testing for PFAS contamination in the Cape Fear River basin. The state found Chemours' current corrective action plan insufficient and too narrow in scope, requiring the company to revise it, expand testing to ten counties, and address all chemicals associated with its Fayetteville Works plant. Chemours has 60 days to respond to these claims, or it could face litigation.
Regulators order Chemours to ‘fully assess’ contamination
North Carolina environmental regulators have ordered Chemours to revise its remediation plan for PFAS contamination in the Lower Cape Fear region, citing "significant deficiencies" in the company's compliance with a 2019 consent order. DEQ expects Chemours to fully assess soil and groundwater contamination, including all associated PFAS, and implement a revised corrective action plan. This directive follows a recent $590 million settlement agreement and ongoing concerns raised by environmental groups about Chemours' failure to meet emission and discharge limits.
The Chemours Company (CC) Stock Price, News, Quote & History
The Chemours Company (CC) stock is currently trading at $13.29, down slightly by 0.45%. The company recently announced a cash dividend of $0.087 with an ex-date of November 16, 2026. Analysts maintain a "Neutral" rating with a target price of $14.00, while the company provides specialty chemicals across various global segments.
North Carolina Vows to Hold Chemours Accountable for Contamination ‘No Matter How Long It Takes’
North Carolina environmental regulators have criticized Chemours' cleanup proposal for widespread PFAS contamination, stating it violates the terms of a consent order. The state's Department of Environmental Quality (DEQ) detailed multiple inadequacies in the company's plan, arguing that Chemours failed to properly assess public health risks and the full extent of pollution. DEQ Secretary Reid Wilson affirmed the state's commitment to holding Chemours accountable, emphasizing that the company must clean up all polluted areas.
Deadline Alert: The Chemours Company Investors Have Until
Investors in The Chemours Company (NYSE: CC) have until December 7, 2026, to seek a lead plaintiff role in a securities fraud class action lawsuit. The lawsuit, filed by Glancy Prongay Wolke & Rotter LLP, alleges that Chemours made materially false and misleading statements regarding aftermarket demand for its Opteon products between February 20, 2026, and August 4, 2026, resulting in significant investor losses. The complaint points to reduced financial guidance and management admissions about oversupplied channels as evidence of the alleged misrepresentations.
State questions Chemours' compliance with clean-up
The N.C. Department of Environmental Quality (DEQ) has identified significant deficiencies in Chemours' compliance with its obligations to address PFAS contamination in groundwater across southeastern North Carolina. DEQ has directed Chemours to fully assess contamination, revise its corrective action plan, expand the plan to include all PFAS, and evaluate remaining emissions. While Chemours has spent $1.2 billion on compliance, the DEQ states it has not finished assessing the contamination's extent or provided an adequate plan to address it.
CC Shareholder Alert: The Chemours Company Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
Levi & Korsinsky, LLP has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) on behalf of investors who purchased securities between February 20, 2026, and August 4, 2026. The lawsuit alleges that Chemours misrepresented demand for its Opteon refrigerant products, claiming that record 2025 sales were due to an overfilled distribution channel, leading to a sales decline in 2026 and an 18.63% drop in share price. Investors who suffered losses are encouraged to contact Levi & Korsinsky and must file to serve as lead plaintiff by December 7, 2026.
CC Securities Notice: Chemours Investors that Suffered Losses when Stock Plummeted 18% are Notified to Contact BFA Law before December 7 Class Action Deadline
Bleichmar Fonti & Auld LLP has filed a class action lawsuit against The Chemours Company (NYSE:CC) and its executives for alleged securities fraud, following an 18.63% stock drop. The lawsuit claims Chemours misrepresented demand for its Opteon products, leading to an oversupplied market. Investors who suffered losses are encouraged to contact BFA Law before the December 7, 2026, lead plaintiff deadline.
North Carolina regulators tell Chemours to expand PFAS cleanup plan
North Carolina environmental regulators are demanding that Chemours expand its PFAS cleanup plan, stating the company's current assessment falls short of its obligations. The Department of Environmental Quality (DEQ) wants Chemours to identify and address all PFAS contamination in groundwater throughout the Lower Cape Fear region, assess health and environmental risks, and account for ongoing plant emissions. Despite Chemours spending $1.2 billion on compliance, DEQ insists more comprehensive action is needed to fully address the pollution.
North Carolina demands stronger action from Chemours on toxic PFAS
North Carolina's Department of Environmental Quality is ordering Chemours to take additional actions to address toxic "forever chemicals" contaminating the state's water. Despite a previous agreement and a recent $600 million settlement, state officials and environmental advocates argue Chemours has failed to meet cleanup requirements, leaving over half a million residents affected. The state has outlined nearly 40 new requirements for the chemical manufacturing company.
The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC (KSF) is reminding investors of The Chemours Company (NYSE: CC) that they have until December 7, 2026, to file lead plaintiff applications in a securities class action lawsuit. The lawsuit alleges that Chemours and its executives failed to disclose material information regarding an oversupplied refrigerant aftermarket channel, leading to a cut in financial guidance and an 18% drop in stock price on August 5, 2026. Investors who purchased Chemours securities between February 20, 2026, and August 4, 2026, are encouraged to contact KSF for legal consultation.
Regulators Direct Chemours to Expand PFAS Cleanup Plans
The North Carolina Department of Environmental Quality (DEQ) has ordered The Chemours Company to revise its PFAS cleanup plans, citing deficiencies in the company's current approach to contamination in the Lower Cape Fear region. DEQ mandates a thorough assessment of soil, groundwater, and associated risks, along with addressing all PFAS linked to the facility and evaluating how ongoing emissions impact groundwater. This directive comes despite Chemours having spent approximately $1.2 billion on compliance efforts, as DEQ claims the company has not yet provided an adequate cleanup plan.
CC Investor Notification: Chemours Sued for Securities Fraud on behalf of Investors with Losses after Opteon Demand Issues Lead to 18% Stock Drop
The Chemours Company (NYSE: CC) is facing a class action lawsuit for securities fraud following an 18.63% stock drop. The lawsuit alleges that Chemours misrepresented the demand for its Opteon products, claiming sustained growth driven by the U.S. AIM Act, while customers were already oversupplied. Investors have until December 7, 2026, to seek appointment as lead plaintiff in the case.
NCDEQ directs Chemours to address deficiencies in its plans to clean up PFAS contamination
The North Carolina Department of Environmental Quality (DEQ) has identified significant deficiencies in Chemours' plans to clean up PFAS contamination across southeastern North Carolina. DEQ is directing Chemours to fully assess contaminated areas, revise its corrective action plan to comply with state law, expand the plan to include all associated PFAS, and evaluate the impact of remaining emissions. Despite Chemours spending $1.2 billion on compliance, the DEQ states that long-term clean-up plans have stalled, prompting this action as part of a September 2026 settlement.
JP Morgan maintains Chemours at Neutral, lowers price target to $14 from $15
JP Morgan has maintained its "Neutral" rating for Chemours but lowered its price target to $14 from $15, representing a 6.7% decrease. This new price target implies a 9.8% upside from Chemours' closing price of $12.75 on November 6. Other recent analyst actions on Chemours show price targets ranging from $15 to $18.
Deadline Alert: The Chemours Company Investors Have Until
Glancy Prongay Wolke & Rotter LLP reminds investors in The Chemours Company (NYSE: CC) that they have until December 7, 2026, to seek a lead plaintiff role in a securities fraud class action lawsuit. The lawsuit alleges that Chemours overstated aftermarket demand for its Opteon products and provided unreliable financial guidance, leading to an 18.63% drop in share price on August 5, 2026. Investors who purchased securities between February 20, 2026, and August 4, 2026, and suffered losses are eligible to participate.
Chemours STEM Education in Action: Inspiring Students Through Hands-On Learning
Chemours is dedicated to expanding access to STEM education through employee volunteerism, community engagement, and immersive learning experiences, inspiring young people to explore science, technology, engineering, and mathematics. Employees bring STEM to life by opening sites for learning, creating hands-on activities like slime-making and tie-dye, and exploring robotics. The company highlights its pride in employees, educators, families, and community partners who help make STEM learning engaging and fun, fostering curiosity and problem-solving skills in the next generation.
CC Stock Alert: Chemours Stock Plummets 18% after Opteon Demand Issues Disclosed – Contact BFA Law about the Pending Securities Fraud Class Action
A class action lawsuit has been filed against The Chemours Company (NYSE:CC) and its executives for securities fraud, following an 18% stock drop on August 5, 2026. The lawsuit alleges that Chemours misrepresented the demand for its Opteon products, failing to disclose that customers were oversupplied due to the U.S. AIM Act transition. Investors have until December 7, 2026, to seek appointment as lead plaintiff in the case, which is pending in the U.S. District Court for the District of Delaware.
The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC (KSF) is reminding investors of The Chemours Company that they have until December 7, 2026, to file lead plaintiff applications in a securities class action lawsuit. The lawsuit alleges that Chemours and its executives failed to disclose material information regarding an oversupplied refrigerant aftermarket channel, which led to an 18.63% drop in stock price after the company cut its full-year adjusted EBITDA guidance. KSF is offering to help investors who suffered substantial losses to understand their legal rights and potential for recovery.
CC Court Deadline Reminder: Chemours Investors Have until December 7 until Expiration of Securities Fraud Class Action Deadline – Contact BFA Law
The Chemours Company (NYSE:CC) is facing a securities fraud class action lawsuit, with investors having until December 7, 2026, to apply as lead plaintiff. The lawsuit alleges that Chemours misrepresented the demand for its Opteon products, leading to an 18.63% stock drop after Q2 2026 financial results revealed oversupplied channels and reduced guidance. Bleichmar Fonti & Auld LLP is representing investors, asserting claims under the Securities Exchange Act of 1934.
Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Chemours Company - CC
ClaimsFiler has issued a shareholder alert for investors in The Chemours Company (NYSE: CC) with losses over $100,000, reminding them of the December 7, 2026, lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Chemours and its executives failed to disclose material information during the Class Period (February 20, 2026, to August 4, 2026), leading to an 18.63% stock drop after the company cut its full-year adjusted EBITDA guidance. ClaimsFiler encourages affected investors to visit their website for more information or a free case evaluation.
Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company and Certain Officers - CC
Pomerantz LLP has filed a class action lawsuit against The Chemours Company and certain officers for allegedly making false and misleading statements about the company's business, operations, and prospects. The lawsuit claims that Chemours materially overstated aftermarket demand for its Opteon products, leading to a decrease in demand and unreliable financial guidance for fiscal year 2026. This allegedly caused the company's stock price to fall significantly after its Q2 2026 financial results and reduced full-year guidance were announced.
CC Launches Faizeon Cooling Solutions to Meet AI Data Center Demand
The Chemours Company (CC) has introduced its Faizeon two-phase liquid cooling solutions to address the increasing demand for advanced cooling in AI, high-performance computing, and high-density data centers. These dielectric fluids are designed for both direct-to-chip and immersion cooling, offering superior heat transfer and reduced energy/water consumption. The launch is expected to strengthen Chemours' market position and capitalize on investments in AI-driven data center infrastructure.
The Chemours Co (CC) (Q3 2026) Earnings Call Highlights: Pricing Momentum and AI-Driven Demand ...
The Chemours Company reported strong Q3 2026 earnings, with net sales up 3% year-over-year and adjusted EBITDA at the high end of guidance, driven by pricing momentum in Titanium Technologies and significant growth in APM's Performance Solutions, particularly in AI infrastructure. The company also announced a strategic launch of the Faizeon product portfolio for two-phase liquid cooling, targeting the growing AI data center market, and has made substantial progress in debt reduction and litigation settlements. Despite some anticipated sequential declines in Q4 for certain segments and persistent macroeconomic uncertainty, management expressed confidence in future earnings growth supported by cost measures and operational improvements.
Chemours Launches New Cooling Fluids to Tackle AI Data Center Heat Surge
Chemours has introduced its new Faizeon™ two-phase liquid cooling solutions, designed to manage the significant heat generated by AI, HPC, and high-density data centers. These advanced dielectric fluids promise lower GPU temperatures, reduced energy consumption, and minimal water use compared to traditional cooling methods. The portfolio, comprising five specialized fluids, aims to address critical thermal management challenges as AI infrastructure rapidly expands.
3M’s “Forever Chemicals” Bill Just Grew by Billions
3M (NYSE: MMM) has agreed to a pre-tax nominal commitment of $7.35 billion over nine years to settle personal injury claims related to AFFF firefighting foam, which contains PFAS "forever chemicals." This settlement covers roughly 99% of 115,000 to 120,000 plaintiffs, but its finalization depends on a yet-undisclosed participation threshold. Despite the significant charge, 3M's 2026 financial guidance remains unchanged, and the company announced a new $6 billion stock buyback.
550,000 Dordrecht area residents seek compensation from Chemours over PFAS
A class-action lawsuit has been launched against chemical company Chemours by a foundation representing approximately 550,000 residents in the Dordrecht area. The foundation, PFAS Vrij Green Claim, seeks to halt Chemours' PFAS emissions and secure compensation for those affected, alleging the company knew about PFAS dangers but failed to disclose risks and take action. The lawsuit highlights long-term exposure to these chemicals, which are linked to various health issues.
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 7, 2026 - CC
Levi & Korsinsky, LLP is reminding investors of The Chemours Company (NYSE: CC) that a securities class action lawsuit is pending, with a lead plaintiff deadline of December 7, 2026. The lawsuit alleges that Chemours made misrepresentations about its TSS channel inventory and Opteon refrigerant aftermarket sales, leading to an 18.63% stock drop after its second-quarter 2026 report. Investors who purchased Chemours securities between February 20, 2026, and August 4, 2026, may be entitled to compensation.
The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC (KSF) is reminding investors of The Chemours Company (NYSE: CC) that they have until December 7, 2026, to file as a lead plaintiff in a securities class action lawsuit. The lawsuit alleges that Chemours and its executives failed to disclose material information regarding an oversupplied refrigerant aftermarket, leading to a cut in full-year adjusted EBITDA guidance and an 18.63% stock price drop on August 5, 2026. Investors who purchased Chemours securities between February 20, 2026, and August 4, 2026, are encouraged to contact KSF to discuss their legal rights.
CC: Amendment: SEC Form 10-K/A filed by Chemours Company
The Chemours Company (CC) filed an Amendment No. 1 to its 2025 annual report (10-K/A), primarily restating sections related to controls and procedures (Item 9A) and exhibits (Item 15(a)(3)). This filing includes new certifications but does not present any changes to the company's reported financial results. Quantisnow, an AI-powered platform, summarized the filing as a "housekeeping correction."
CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP (SBS) has reminded investors of a class action lawsuit against The Chemours Company (NYSE: CC) for alleged securities fraud. The lawsuit claims Chemours made false and misleading statements about demand for its Opteon products and that its 2026 fiscal guidance was unreliable. Shareholders who purchased CC shares between February 20, 2026, and August 4, 2026, are encouraged to contact SBS before the December 7, 2026, deadline to discuss potential lead plaintiff appointments.
The Chemours Company Q3 2026 Earnings Call Is Live
The Chemours Company has just begun its quarterly earnings call for Q3 2026. During the call, executives will discuss the latest financial results with Wall Street analysts and potentially announce surprise news. Investors and followers of CC are encouraged to listen to management's commentary on future demand, margins, or capital spending, as this can significantly influence market movements.